Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells (Q24316364)

Peroxisome proliferator activated receptor gamma

1 reference

Fas ligand

1 reference

activation of cysteine-type endopeptidase activity involved in apoptotic process

1 reference

breast cancer

1 reference

Erratum to: Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells

inferred from title

corrigendum / erratum

0 references

Daniela Bonofiglio

1

0 references

Stefania Catalano

object named as

Stefania Catalano

6

0 references

Saveria Aquila

object named as

Saveria Aquila

3

0 references

author name string

Sabrina Gabriele

2

0 references

Hongyan Qi

4

0 references

Maria Belmonte

5

0 references

Sebastiano Andò

Breast Cancer Research and Treatment

7

0 references

language of work or name

English

0 references

publication date

February 2009

0 references

published in

0 references

volume

113

0 references

page(s)

423-34

0 references

issue

3

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s10549-008-9944-1

0 references

cites work

Recent advances in peroxisome proliferator-activated receptor science

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

The Cyclopentenone-Type Prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits CD95 Ligand Gene Expression in T Lymphocytes: Interference with Promoter Activation Via Peroxisome Proliferator-Activated Receptor-γ-Independent Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Fas ligand expression in TM4 Sertoli cells is enhanced by estradiol "in situ" production.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

CD95 ligand expression in dedifferentiated breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Portrait of an executioner: the molecular mechanism of FAS/APO-1-induced apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

CD95L/FasL and TRAIL in tumour surveillance and cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Cellular catabolism in apoptosis: DNA degradation and endonuclease activation.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Apoptosis pathways in cancer and cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

The many faces of PPARgamma

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

An overview on biological mechanisms of PPARs.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Apoptotic pathways: the roads to ruin

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Sequential involvement of NFAT and Egr transcription factors in FasL regulation

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Fas ligand, death gene.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Constitutive Fas ligand gene transcription in Sertoli cells is regulated by Sp1.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Interleukin 1beta induces type II-secreted phospholipase A(2) gene in vascular smooth muscle cells by a nuclear factor kappaB and peroxisome proliferator-activated receptor-mediated process

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

A tale of three fingers: the family of mammalian Sp/XKLF transcription factors

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

DNA damage signals induction of fas ligand in tumor cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

1 reference

7 January 2021

Nuclear receptors and the control of metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

A non-radioactive method for inexpensive quantitative RT-PCR

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Therapeutic potential of thiazolidinediones as anticancer agents

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agents

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021

Bifunctional properties of peroxisome proliferator-activated receptor gamma1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-008-9944-1

7 January 2021